Point72 Hong Kong LTD Biomarin Pharmaceutical Inc Transaction History

Point72 Hong Kong LTD

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $788,735 - $931,689	9,411 New	9,411 $821,000
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $560,117 - $680,556	-7,836 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $205,532 - $256,473	2,767 Added 54.59%	7,836 $604,000
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $363,548 - $463,661	5,069 New	5,069 $448,000
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $639,267 - $717,832	-8,466 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $632,664 - $767,781	8,466 New	8,466 $639,000
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $18,296 - $28,570	-230 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $16,415 - $22,275	230 New	230 $19,000
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $77,914 - $98,387	-1,156 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $5,624 - $6,573	-70 Reduced 5.71%	1,156 $99,000
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $90,767 - $106,312	1,078 Added 728.38%	1,226 $109,000
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $72,366 - $95,781	-903 Reduced 85.92%	148 $13,000
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $95,986 - $108,045	1,022 Added 3524.14%	1,051 $102,000
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $2,204 - $2,871	29 New	29 $3,000
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $108,738 - $129,682	-1,400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $113,064 - $133,182	1,400	1,400 $125,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.